(Q53262764)

12 May 2018

title

Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells. (English)

1 reference

12 May 2018

main subject

angiogenesis inhibitor

1 reference

Chikara Muraki

1

1 reference

12 May 2018

Noritaka Ohga

2

1 reference

12 May 2018

Yasuhiro Hida

3

1 reference

12 May 2018

Hiroshi Nishihara

4

1 reference

12 May 2018

Yasutaka Kato

5

1 reference

12 May 2018

Kunihiko Tsuchiya

6

1 reference

12 May 2018

Kohei Matsuda

7

1 reference

12 May 2018

Yasunori Totsuka

8

1 reference

12 May 2018

Masanobu Shindoh

9

1 reference

12 May 2018

Kyoko Hida

10

1 reference

12 May 2018

language of work or name

English

0 references

publication date

20 April 2011

1 reference

12 May 2018

International Journal of Cancer

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

12 May 2018

volume

130

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

59-70

1 reference

12 May 2018

The tumour microenvironment as a target for chemoprevention.

cites work

1 reference

Angiogenesis as a therapeutic target

21 January 2018

1 reference

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

Host cyclooxygenase-2 modulates carcinoma growth.

21 January 2018

1 reference

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel

21 January 2018

1 reference

Regulation of angiogenesis by hypoxia: role of the HIF system

21 January 2018

1 reference

Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells

21 January 2018

1 reference

Endothelial cell COX-2 expression and activity in hypoxia

21 January 2018

1 reference

Genes expressed in human tumor endothelium

21 January 2018

1 reference

Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors

21 January 2018

1 reference

The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation

21 January 2018

1 reference

Dkk-3 expression in the tumor endothelium: a novel prognostic marker of pancreatic adenocarcinomas

21 January 2018

1 reference

Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors

21 January 2018

1 reference

Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells

21 January 2018

1 reference

Tumor-associated endothelial cells with cytogenetic abnormalities.

21 January 2018

1 reference

Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors

21 January 2018

1 reference

NS-398, a selective cyclooxygenase-2 inhibitor, reduces experimental bladder carcinoma outgrowth by inhibiting tumor cell proliferation

21 January 2018

1 reference

Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity

21 January 2018

1 reference

Isolated tumor endothelial cells maintain specific character during long-term culture

21 January 2018

1 reference

Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.

21 January 2018

1 reference

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies

21 January 2018

1 reference

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

Contribution of bone marrow–derived endothelial cells to human tumor vasculature

21 January 2018

1 reference

Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells

21 January 2018

1 reference

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

21 January 2018

1 reference

Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.

21 January 2018

1 reference

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

21 January 2018

1 reference

Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy

21 January 2018

1 reference

Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study.

21 January 2018

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25976

1 reference

12 May 2018

1 reference

12 May 2018